Pengana International Equities has settled Supreme Court proceedings and agreed steps aimed at ending a related Takeovers Panel application, clearing a path for its buy-back and strategic reset. Antipodes will manage the portfolio under a new Board led by interim chairman Frank Gooch after the transaction.
- Settlement ends Supreme Court challenge to the buy-back
- Antipodes appointed to manage the Global SMID portfolio
- Four directors to resign after buy-back completion
- Shareholders can withdraw buy-back elections until 24 September
- PCG will not participate; WAM plans to retain up to 2.69%
PIA Settlement Removes Buy-Back Litigation Uncertainty
Pengana International Equities Limited (ASX:PIA) has settled the legal dispute threatening to complicate its buy-back, with the Supreme Court proceedings set to be discontinued by consent. Pengana Capital Group Limited (ASX:PCG) will also seek to bring its Takeovers Panel application to an end, although that step remains subject to any consent, leave or orders required from the Panel.
The settlement is without admission of liability or wrongdoing. Its practical effect is more important than its legal wording: PIA can now proceed with the buy-back, portfolio transition and governance overhaul without the immediate uncertainty of two live challenges. The buy-back closing date remains 21 September 2026, while shareholders who have already tendered shares can withdraw all or part of their election until 5.00pm Sydney time on 24 September.
Antipodes Appointed to Lead Global SMID Strategy
The Board has approved Antipodes Partners as PIA’s sub-investment manager. Following completion of the buy-back, the portfolio will transition to Antipodes’ Global Small and Mid-Cap strategy. The company said Antipodes manages more than A$20 billion globally and described the appointment as a central outcome of its strategic review.
That transition gives the listed investment company a new investment platform, but the filing does not provide a timetable or performance targets. PIA said further details on implementation would be released in due course, leaving the execution of the handover and the strategy’s ability to improve the company’s market relevance as the next material tests.
Board Recast After Buy-Back Completion
Frank Gooch and Brendan O’Dea join the Board immediately. Geoff Wilson, Jesse Hamilton, Julian Martin and Brett Jollie will remain directors until the buy-back is completed and are then expected to resign with effect from 29 September 2026, the anticipated completion date.
Gooch will become interim Chairman and lead the search for additional independent directors. The settlement says the intended end state is a Board predominantly independent of both WAM and PCG, with responsibility for overseeing PIA’s investment management, strategy and capital management arrangements.
Future Dividends and Discount Management Remain Conditional
After the buy-back and portfolio transition, the Board intends to continue quarterly fully franked dividends, subject to profits, franking capacity and Board discretion. Following a stabilisation period, it also intends to consider mechanisms including a rolling quarterly buy-back within regulatory and solvency limits, giving continuing shareholders a possible route to realise value around net tangible asset value.
Those plans are intentions rather than guaranteed distributions or transactions. The reconstituted Board will first assess PIA’s capital requirements and then decide whether any future capital raising should proceed. PCG and its subsidiaries have indicated they will not participate in the current buy-back, while Wilson Asset Management Group intends to retain no more than 2.69% of PIA’s issued capital before the buy-back.
Bottom Line?
The legal overhang has receded, but the investment case now turns on buy-back completion, the Antipodes handover and whether the new Board can turn conditional capital-management plans into durable shareholder value.
Questions in the middle?
- Will the Takeovers Panel formally bring PCG’s application to an end before the buy-back completes?
- How many shares will ultimately be bought back after the extended withdrawal opportunity?
- Can Antipodes and the incoming independent directors establish a credible long-term strategy for PIA?